SE398876B - Sett att framstella basiska 1,4-dihydropyridinkarbonsyraestrar - Google Patents
Sett att framstella basiska 1,4-dihydropyridinkarbonsyraestrarInfo
- Publication number
- SE398876B SE398876B SE7305462A SE7305462A SE398876B SE 398876 B SE398876 B SE 398876B SE 7305462 A SE7305462 A SE 7305462A SE 7305462 A SE7305462 A SE 7305462A SE 398876 B SE398876 B SE 398876B
- Authority
- SE
- Sweden
- Prior art keywords
- dihydropyridincarbonic
- acid esters
- preparing basic
- preparing
- basic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2218644A DE2218644C3 (de) | 1972-04-18 | 1972-04-18 | Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
SE398876B true SE398876B (sv) | 1978-01-23 |
Family
ID=5842285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7305462A SE398876B (sv) | 1972-04-18 | 1973-04-17 | Sett att framstella basiska 1,4-dihydropyridinkarbonsyraestrar |
Country Status (22)
Country | Link |
---|---|
US (1) | US3905970A (de) |
JP (2) | JPS5637225B2 (de) |
AT (7) | ATA45775A (de) |
AU (1) | AU467406B2 (de) |
BE (1) | BE798403A (de) |
CA (1) | CA1006515A (de) |
CH (6) | CH591445A5 (de) |
CS (6) | CS174249B2 (de) |
DD (1) | DD107275A5 (de) |
DE (1) | DE2218644C3 (de) |
DK (1) | DK137753C (de) |
ES (1) | ES413809A1 (de) |
FI (1) | FI55997C (de) |
FR (1) | FR2182983B1 (de) |
GB (1) | GB1383625A (de) |
HU (1) | HU167989B (de) |
IE (1) | IE37538B1 (de) |
IL (1) | IL42044A (de) |
NL (1) | NL176942C (de) |
SE (1) | SE398876B (de) |
SU (6) | SU518127A3 (de) |
ZA (1) | ZA732633B (de) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4038399A (en) * | 1972-04-18 | 1977-07-26 | Bayer Aktiengesellschaft | 1,4-dihydropyridine carboxylic acid esters useful as coronary vessel dilators and anti-hypertensives |
FR2218107A1 (en) * | 1973-02-20 | 1974-09-13 | Yamanouchi Pharma Co Ltd | Amino alkyl 2,6-dialkyl-4-aryl-1,4 dihydropyridine-3, carboxylates - useful as cerebral vasodilators and musculotropic spasmolytic agents |
US3985758A (en) * | 1973-02-20 | 1976-10-12 | Yamanouchi Pharmaceutical Co., Ltd. | 1,4-Dihydropyridine derivatives |
DE2508181A1 (de) * | 1975-02-26 | 1976-09-09 | Bayer Ag | 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
FR2320750A1 (fr) * | 1975-08-12 | 1977-03-11 | Hexachimie | Dihydro-1,4 pyridines et leur application therapeutique |
DE2738153A1 (de) * | 1977-08-24 | 1979-03-08 | Bayer Ag | 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
JPS55301A (en) * | 1978-02-14 | 1980-01-05 | Yamanouchi Pharmaceut Co Ltd | 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation |
US4285955A (en) * | 1978-10-31 | 1981-08-25 | Bayer Aktiengesellschaft | 1,4-Dihydropyridinecarboxylic acids |
DE2847237A1 (de) * | 1978-10-31 | 1980-05-14 | Bayer Ag | Verfahren zur herstellung von 1,4-dihydropyridincarbonsaeuren sowie ihre verwendung als arzneimittel |
DE2949464A1 (de) * | 1978-12-18 | 1980-06-26 | Sandoz Ag | Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung |
JPS57171968A (en) * | 1981-04-17 | 1982-10-22 | Kyowa Hakko Kogyo Co Ltd | 1,4-dihydropyridine derivative |
JPS57200386A (en) * | 1981-06-04 | 1982-12-08 | Yoshitomi Pharmaceut Ind Ltd | Novel 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salts |
NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
FR2511370B1 (fr) * | 1981-08-12 | 1986-10-24 | Tokyo Tanabe Co | Derives de 1,4-dihydropyridine a activite vasodilatatrice et d'hypotension |
JPS58131982A (ja) * | 1982-02-01 | 1983-08-06 | Tokyo Tanabe Co Ltd | 新規なる1.4−ジヒドロピリジン誘導体 |
JPS58159490A (ja) * | 1982-02-23 | 1983-09-21 | Nikken Kagaku Kk | 1,4−ジヒドロピリジン化合物 |
WO1983003249A1 (en) * | 1982-03-17 | 1983-09-29 | Yoshitomi Pharmaceutical | 1,4-dihydropyridine-3,5-dicarboxylate derivatives |
JPS58201765A (ja) * | 1982-05-10 | 1983-11-24 | Takeda Chem Ind Ltd | ジヒドロピリジン誘導体,その製造法および用途 |
EP0094159B1 (de) * | 1982-05-10 | 1990-03-14 | Takeda Chemical Industries, Ltd. | Dihydropyridinderivate, deren Herstellung und Verwendung |
EP0097821B1 (de) * | 1982-06-03 | 1988-07-13 | Pierrel S.p.A. | Dihydropyridine mit Calciumantagonistischer Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
US4419518A (en) * | 1982-07-26 | 1983-12-06 | Tokyo Tanabe Co. L.T.D. | 1,4-Dihydropyridine derivatives |
PH19166A (en) * | 1982-09-04 | 1986-01-16 | Pfizer | Dihydropyridined,pharmaceutical compositions and method of use |
JPS5951281A (ja) * | 1982-09-17 | 1984-03-24 | Yoshitomi Pharmaceut Ind Ltd | 1,4−ジヒドロピリジン−3,5−ジカルボン酸エステル誘導体 |
DE3234684A1 (de) * | 1982-09-18 | 1984-03-22 | Bayer Ag, 5090 Leverkusen | Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
JPS5970667A (ja) * | 1982-10-15 | 1984-04-21 | Kyowa Hakko Kogyo Co Ltd | 1,4−ジヒドロピリジン誘導体 |
EP0106275B1 (de) * | 1982-10-15 | 1991-03-13 | Kyowa Hakko Kogyo Co., Ltd. | 1,4-Dihydropyridin-Derivate |
JPS5970666A (ja) * | 1982-10-15 | 1984-04-21 | Kyowa Hakko Kogyo Co Ltd | 1,4−ジヒドロピリジン誘導体 |
JPS59225162A (ja) * | 1983-06-03 | 1984-12-18 | Kyowa Hakko Kogyo Co Ltd | 1,4−ジヒドロピリジン誘導体 |
US4656181A (en) * | 1982-11-24 | 1987-04-07 | Cermol S.A. | Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same |
US4491582A (en) * | 1983-03-03 | 1985-01-01 | Usv Pharmaceutical Corporation | N-(substituted piperazino)-1,4-dihydropyridine-3,5-carboxylic acid |
AU561213B2 (en) * | 1983-06-02 | 1987-04-30 | Teijin Limited | 1, 4-dihydropyridine derivative |
US4603135A (en) * | 1983-10-17 | 1986-07-29 | Takeda Chemical Industries, Ltd. | Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates |
JPS6092266A (ja) * | 1983-10-27 | 1985-05-23 | Teijin Ltd | 1,4−ジヒドロピリジン−3,5−ジカルボン酸ジエステル誘導体,その製造法及びそれを有効成分とする薬剤 |
JPS60120861A (ja) * | 1983-12-02 | 1985-06-28 | Otsuka Pharmaceut Co Ltd | ジヒドロピリジン誘導体 |
DE4342196A1 (de) * | 1993-12-10 | 1995-06-14 | Bayer Ag | Neue 4-Phenyl-substituierte 1,4-Dihydropyridine |
JPS60156671A (ja) * | 1984-01-25 | 1985-08-16 | Yamanouchi Pharmaceut Co Ltd | ジヒドロピリジン誘導体およびその製造法 |
IE57810B1 (en) * | 1984-03-27 | 1993-04-21 | Delagrange Lab | 1,4-dihydropyridine derivatives,their preparation and their use |
US4895846A (en) * | 1984-04-11 | 1990-01-23 | Bristol-Myers Company | Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moieties |
US4755512A (en) * | 1984-04-11 | 1988-07-05 | Bristol-Myers Company | Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moities |
WO1986001081A1 (en) * | 1984-08-03 | 1986-02-27 | Mitsui & Co., Ltd | Method of and apparatus for freezing food |
JPS6147477A (ja) * | 1984-08-14 | 1986-03-07 | Kowa Co | 新規1,4−ジヒドロピリジン−3,5−ジカルボン酸エステル誘導体 |
US4757071A (en) * | 1984-12-14 | 1988-07-12 | Nisshin Flour Milling Co., Ltd. | 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases |
JPH0676405B2 (ja) * | 1986-06-13 | 1994-09-28 | 日清製粉株式会社 | 1,4―ジヒドロピリジン誘導体およびそれを含有する医薬組成物 |
US4652573A (en) * | 1985-03-14 | 1987-03-24 | Nelson Research & Development Co. | Calcium antagonist N-hetero ester 1,4-dihydropyridines |
US4833150A (en) * | 1985-03-14 | 1989-05-23 | Nelson Research & Development Co. | 1,4-dihydropyridines |
US4593033A (en) * | 1985-04-24 | 1986-06-03 | Merck & Co., Inc. | Substituted indeno[2,1-c] pyridines useful as calcium channel blockers |
DK8602336A (de) * | 1985-05-21 | 1986-11-22 | ||
US4605660A (en) * | 1985-06-03 | 1986-08-12 | Merck & Co., Inc. | Indeno[2,1-c]pyridine compounds, and their use as calcium channel blockers |
US4670443A (en) * | 1985-07-02 | 1987-06-02 | Merck & Co., Inc. | Benzo(f)isoquinoline compounds useful as calcium entry blockers |
US4735956A (en) * | 1985-09-13 | 1988-04-05 | Merck & Co., Inc. | Certain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockers |
DE3682857D1 (en) * | 1985-09-13 | 1992-01-23 | Green Cross Corp | Dihydropyridinderivate. |
IT1201476B (it) * | 1985-10-04 | 1989-02-02 | Yason Srl | Derivato diidropiridinico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono |
US4721708A (en) * | 1985-11-26 | 1988-01-26 | Merck & Co., Inc. | Cyclized N-substituted-tetrahydropyridine compounds and cardiovascular use |
US4788203A (en) * | 1985-11-26 | 1988-11-29 | Merck & Co., Inc. | Cyclized N-substituted-tetrahydropyridine compounds, useful in the treatment of cardiovascular disorders |
US4771057A (en) * | 1986-02-03 | 1988-09-13 | University Of Alberta | Reduced pyridyl derivatives with cardiovascular regulating properties |
US4849436A (en) * | 1986-03-11 | 1989-07-18 | Nelson Research & Development Co. | 1,4-dihydropyridines |
HU196755B (en) * | 1986-09-16 | 1989-01-30 | Gyogyszerkutato Intezet | Process for production of new substituated amilid derivatives and medical compositions containing them |
WO1988009331A1 (en) * | 1987-05-22 | 1988-12-01 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Process for manufacturing carboxylic acids |
DE3732380A1 (de) * | 1987-09-25 | 1989-04-06 | Bayer Ag | Dihydropyridinether, verfahren zu ihrer herstellung und ihre verwendung |
US5216172A (en) * | 1988-02-24 | 1993-06-01 | Ajinomoto Co., Inc. | 1,4-dihydropyridine-4-aryl-2,6-dimethyl-3,5-dicarboxylates useful as agents against drug resistant tumor cells |
EP0330470A3 (de) * | 1988-02-24 | 1992-01-02 | Ajinomoto Co., Inc. | Gegen Tumorzellen verwendbare 1,4-Dihydropyridin-Derivate |
ES2059767T3 (es) * | 1988-07-28 | 1994-11-16 | Nikken Chemicals Co Ltd | Derivado de 1,4-dihidropiridina. |
DE4342195A1 (de) * | 1993-12-10 | 1995-06-14 | Bayer Ag | Dihydropyridine mit heterocyclisch substituierten Estern |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1545873A1 (de) * | 1965-11-10 | 1970-02-26 | Bayer Ag | Verfahren zur Herstellung von Dihydrodipyridylderivaten |
DE1670827C3 (de) * | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
DE1923990C3 (de) * | 1969-05-10 | 1978-11-23 | Bayer Ag | Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern |
DE1963185A1 (de) * | 1969-12-17 | 1971-06-24 | Bayer Ag | Neue Nitrophenyl-1,4-dihydropyridinderivate |
DE2117571C3 (de) * | 1971-04-10 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
-
1972
- 1972-04-18 DE DE2218644A patent/DE2218644C3/de not_active Expired
-
1973
- 1973-04-12 US US350381A patent/US3905970A/en not_active Expired - Lifetime
- 1973-04-13 AU AU54491/73A patent/AU467406B2/en not_active Expired
- 1973-04-16 SU SU1911372A patent/SU518127A3/ru active
- 1973-04-16 AT AT45775*A patent/ATA45775A/de not_active IP Right Cessation
- 1973-04-16 AT AT45875*7A patent/AT329559B/de not_active IP Right Cessation
- 1973-04-16 JP JP4225373A patent/JPS5637225B2/ja not_active Expired
- 1973-04-16 JP JP48042254A patent/JPS4914614A/ja active Pending
- 1973-04-16 IL IL42044A patent/IL42044A/xx unknown
- 1973-04-16 AT AT337373A patent/AT327191B/de not_active IP Right Cessation
- 1973-04-16 AT AT45975*7A patent/AT329560B/de not_active IP Right Cessation
- 1973-04-16 DD DD170202A patent/DD107275A5/xx unknown
- 1973-04-16 AT AT45775*7A patent/AT327905B/de not_active IP Right Cessation
- 1973-04-16 FI FI1193/73A patent/FI55997C/fi active
- 1973-04-16 AT AT45975*A patent/ATA45975A/de not_active IP Right Cessation
- 1973-04-16 CA CA168,760A patent/CA1006515A/en not_active Expired
- 1973-04-16 AT AT45875*A patent/ATA45875A/de not_active IP Right Cessation
- 1973-04-17 CH CH319276A patent/CH591445A5/xx not_active IP Right Cessation
- 1973-04-17 CS CS6248A patent/CS174249B2/cs unknown
- 1973-04-17 CH CH554373A patent/CH589627A5/xx not_active IP Right Cessation
- 1973-04-17 CS CS2764A patent/CS174201B2/cs unknown
- 1973-04-17 CS CS6245A patent/CS174246B2/cs unknown
- 1973-04-17 CS CS6246A patent/CS174247B2/cs unknown
- 1973-04-17 CH CH319076A patent/CH590841A5/xx not_active IP Right Cessation
- 1973-04-17 CS CS6247A patent/CS174248B2/cs unknown
- 1973-04-17 ZA ZA732633A patent/ZA732633B/xx unknown
- 1973-04-17 CH CH319376A patent/CH588464A5/xx not_active IP Right Cessation
- 1973-04-17 ES ES413809A patent/ES413809A1/es not_active Expired
- 1973-04-17 SE SE7305462A patent/SE398876B/xx unknown
- 1973-04-17 DK DK208973A patent/DK137753C/da not_active IP Right Cessation
- 1973-04-17 IE IE604/73A patent/IE37538B1/xx unknown
- 1973-04-17 CS CS6249A patent/CS174250B2/cs unknown
- 1973-04-17 CH CH319176A patent/CH590842A5/xx not_active IP Right Cessation
- 1973-04-17 CH CH319476A patent/CH591446A5/xx not_active IP Right Cessation
- 1973-04-18 FR FR7314175A patent/FR2182983B1/fr not_active Expired
- 1973-04-18 HU HUBA2916A patent/HU167989B/hu unknown
- 1973-04-18 NL NLAANVRAGE7305479,A patent/NL176942C/xx not_active IP Right Cessation
- 1973-04-18 GB GB1872573A patent/GB1383625A/en not_active Expired
- 1973-04-18 BE BE130166A patent/BE798403A/xx not_active IP Right Cessation
-
1974
- 1974-06-13 SU SU2032539A patent/SU516351A3/ru active
- 1974-06-13 SU SU2032541A patent/SU516352A3/ru active
- 1974-06-13 SU SU2032540A patent/SU513620A3/ru active
- 1974-06-13 SU SU2032538A patent/SU515452A3/ru active
- 1974-06-13 SU SU2032542A patent/SU513621A3/ru active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE398876B (sv) | Sett att framstella basiska 1,4-dihydropyridinkarbonsyraestrar | |
SE393603B (sv) | Sett att framstella lagalkylestrar av aspartylaminosyra | |
SE428218B (sv) | Forfarande for framstellning av 6-aminopenicillansyra | |
SE410607B (sv) | Sett att framstella pregnan-21-syraderivat | |
SE403478B (sv) | Sett att framstella 2,2,6,6-tetrametyl-4-oxopiperidin | |
SE414164B (sv) | Forfarande for framstellning av fosforsyra | |
NO137589C (no) | Fremgangsmaate for fremstilling av fosforsyre | |
SE392103B (sv) | Sett att framstella 1,2-bensisotiazolin-3-oner | |
SE385707B (sv) | Sett att framstella 8,9-didehydro-10-alkoxi-ergolenderivat | |
SE428692B (sv) | Forfarande for framstellning av 7beta-amino-3-cefem-4-karboxylsyraforeningar | |
SE7603277L (sv) | Sett att framstella prostansyraderivat | |
SU479291A3 (ru) | Способ получени амидов 2,5-диметилфуран-3-карбоновой кислоты | |
NO147644C (no) | Fremgangsmaate for fremstilling av 6-amino-penicillansyre | |
SE397190B (sv) | Sett att framstella substituerade dibensocykloheptener | |
SE409458B (sv) | Sett att framstella 7-amino-desacetoxi-cefalosporansyra | |
SE401187B (sv) | Sett att framstella delta4-3-ketosteroid-17-propiolakton | |
SE399712B (sv) | Sett att framstella pregnansyraderivat | |
SE7504980L (sv) | Sett att framstella salter av poly-alfa-hydroxiakrylsyror. | |
SE382063B (sv) | Sett att framstella fenyl-vinylfosfonsyraderivat | |
SE405118B (sv) | Sett att framstella 2,4-diamino-5-bensylpyrimidiner | |
SE404192B (sv) | Sett att framstella 3 beta-cykloalkyloxi-16 alfa-cyanopregn-5-en-20-oner | |
SE403102B (sv) | Sett att framstella indan-1-karboxylsyraderivat | |
SU528868A3 (ru) | Способ получени алкоксиациламинофенилацетамидинов или их солей | |
AT323128B (de) | Verfahren zur herstellung von succinylobernsteinsäurediestern (2,5-dioxocyclohexan-1,4-dicarbonsäureesteen) | |
SE383334B (sv) | Sett att framstella substituerade 1,5-dioxo-hexahydroindan-4-karbonsyraderivat |